Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
Operating Income Contraction
Profitability under pressure
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-8.13M
↑ 13% above average
Average (9y)
$-9.32M
Historical baseline
Range
High:$-5.41M
Low:$-14.14M
CAGR
+2.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-8.13M | +0.8% |
| 2023 | $-8.20M | +18.8% |
| 2022 | $-10.10M | +21.4% |
| 2021 | $-12.84M | +9.2% |
| 2020 | $-14.14M | -17.8% |
| 2019 | $-12.01M | -121.8% |
| 2018 | $-5.41M | +26.6% |
| 2017 | $-7.38M | +14.6% |
| 2016 | $-8.63M | -34.6% |
| 2015 | $-6.42M | - |